Katerina Hadrava Vanova

Also affiliated with Eunice Kennedy Shriver National Institute of Child Health and Human Development

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 17 papers. Top paper: “Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis”.

Histone H3.3G34-Mutant Interneuron Progenitors Co-opt PDGFRA for Gliomagenesis

Cell(2020)10.1016/j.cell.2020.11.012

N/A

0DataRank · unranked

200 citations

Shriya Deshmukh, Selin Jessa, Djihad Hadjadj, Véronique Lisi, Augusto Faria Andrade +59 more

Therapeutic Targeting of SDHB -Mutated Pheochromocytoma/Paraganglioma with Pharmacologic Ascorbic Acid

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-19-2335

N/A

0DataRank · unranked

44 citations

Ying Pang, Boqun Zhu, Ondřej Uher, Veronika Caisová, Thanh‐Truc Huynh +8 more

Succinate Mediates Tumorigenic Effects via Succinate Receptor 1: Potential for New Targeted Treatment Strategies in Succinate Dehydrogenase Deficient Paragangliomas

Frontiers in Endocrinology(2021)10.3389/fendo.2021.589451

N/A

0DataRank · unranked

45 citations

Katerina Hadrava Vanova, Nicole Bechmann, Susan Richter, Julica Folberth, Hans K. Ghayee +16 more

Germline SUCLG2 Variants in Patients With Pheochromocytoma and Paraganglioma

JNCI Journal of the National Cancer Institute(2021)10.1093/jnci/djab158

N/A

0DataRank · unranked

35 citations

Ying Pang, Linda Krobova, Michal Kraus, Zuzana Nahácka, Štěpána Boukalová +23 more

Immune signature of pheochromocytoma and paraganglioma in context of neuroendocrine neoplasms associated with prognosis

Endocrine(2022)10.1007/s12020-022-03218-1

N/A

0DataRank · unranked

23 citations

Katerina Hadrava Vanova, Ondřej Uher, Shaoli Das, Mayank Patel, Leah Meuter +12 more

PD-L1 expression and association with genetic background in pheochromocytoma and paraganglioma

Frontiers in Oncology(2022)10.3389/fonc.2022.1045517

N/A

0DataRank · unranked

11 citations

Ondřej Uher, Leah Meuter, Suman Ghosal, Sara Talvacchio, Mayank Patel +3 more

Disordered-to-ordered transitions in assembly factors allow the Complex II catalytic subunit to switch binding partners

Research Square(2022)10.21203/rs.3.rs-2070392/v1

N/A

0DataRank · unranked

1 citations

Elena Maklashina, Markus Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus +12 more

Intratumoral immunotherapy of murine pheochromocytoma shows no age-dependent differences in its efficacy

Frontiers in Endocrinology(2023)10.3389/fendo.2023.1030412

N/A

0DataRank · unranked

7 citations

Katerina Hadrava Vanova, Radka Lencova, Andrea Frejlachova, Herui Wang, Zhengping Zhuang +3 more

The Immune Landscape of Pheochromocytoma and Paraganglioma: Current Advances and Perspectives

Endocrine Reviews(2024)10.1210/endrev/bnae005

N/A

0DataRank · unranked

21 citations

Katerina Hadrava Vanova, David Taïeb, Bruna Calsina, Mercedes Robledo, Roderick Clifton‐Bligh +2 more

rWTC‐MBTA Vaccine Induces Potent Adaptive Immune Responses Against Glioblastomas via Dynamic Activation of Dendritic Cells

Advanced Science(2024)10.1002/advs.202308280

N/A

0DataRank · unranked

14 citations

Rogelio Medina, Juan Ye, Yaping Zhang, Samik Chakraborty, Alex Valenzuela +10 more

Disordered-to-ordered transitions in assembly factors allow the complex II catalytic subunit to switch binding partners

Nature Communications(2024)10.1038/s41467-023-44563-7

N/A

0DataRank · unranked

9 citations

Elena Maklashina, Markus Voehler, Sona Balintova, Sarka Dvorakova, Michal Kraus +13 more

Role of B cells in intratumoral MBTA immunotherapy of murine pheochromocytoma model

Best Practice & Research Clinical Endocrinology & Metabolism(2024)10.1016/j.beem.2024.101941

N/A

0DataRank · unranked

3 citations

Katerina Hadrava Vanova, Kateřina Petrláková, Rachael N. Labitt, Radka Lencova, Andrea Frejlachova +7 more

Niche for polyamine inhibition in treatment of metastatic pheochromocytoma and paraganglioma

European Journal of Clinical Investigation(2024)10.1111/eci.14162

N/A

0DataRank · unranked

1 citations

Heather Hatch, Raymond J. Bergeron, Katerina Hadrava Vanova, Karel Pacák, Sergei G. Tevosian +1 more

Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer

Frontiers in Immunology(2025)10.3389/fimmu.2024.1479483

N/A

0DataRank · unranked

20 citations

Katerina Hadrava Vanova, Ondřej Uher, Jindřiška Leischner Fialová, Kateřina Petrláková, Michal Masařík +5 more

Neoadjuvant intratumoral MBT(A) immunotherapy prevents distant metastases and recurrence in murine models

Cancer Letters(2025)10.1016/j.canlet.2025.217464

N/A

0DataRank · unranked

7 citations

Katerina Hadrava Vanova, Rachael N. Labitt, Kateřina Petrláková, Juan Ye, Herui Wang +6 more

Development of succinate dehydrogenase subunit B-deficient tumor models for preclinical immunotherapy testing

Cancer Letters(2025)10.1016/j.canlet.2025.217969

N/A

0DataRank · unranked

2 citations

Ondřej Uher, Michal Kraus, Sona Miklovicova, Kateřina Hönigová, Stanislaw Gwiezdzinski +9 more

Block, expose, and immunize: triple attack on cancer

Trends in Molecular Medicine(2025)10.1016/j.molmed.2025.06.009

N/A

0DataRank · unranked

0 citations

Katerina Hadrava Vanova, Martina Raudenská, Ondřej Uher, Zdeněk Kejík, Milan Jakubek +3 more